Gene Disease Score gda Association Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 384
Gene Symbol: ARG2
ARG2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1α, markers of hypoxia, in PDC tissue. 23424623

2013

Entrez Id: 55515
Gene Symbol: ASIC4
ASIC4
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 GeneticVariation BEFREE Here, we show that ASIC4 maps to the long arm of chromosome 2 in close proximity to the locus for paroxysmal dystonic choreoathetosis (PDC), a movement disorder with unknown cause. 11571555

2001

Entrez Id: 8030
Gene Symbol: CCDC6
CCDC6
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE The relatively low prevalence of RET activation in PDCs argues against a major role for RET/PTC in the progression from well to poorly differentiated thyroid tumor phenotypes. 11788678

2002

Entrez Id: 929
Gene Symbol: CD14
CD14
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE The experiment lasted for six weeks, and peripheral blood samples were collected from the animals for analyses of selected morphological parameters and changes in the percentages of CD4⁺8<sup>-</sup>, CD4<sup>-</sup>8⁺, and CD4⁺8⁺ lymphocytes and antigen-presenting cells (APC) with CD14⁺172⁺ (monocytes), CD172a<sup>high</sup>4<sup>-</sup>14<sup>-</sup> (conventional dendritic cells, cDC), and CD172a<sup>dim</sup>4⁺14<sup>-</sup> (plasmacytoid dendritic cells, pDC) phenotypes. 28445424

2017

Entrez Id: 999
Gene Symbol: CDH1
CDH1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 AlteredExpression BEFREE Among diffuse type GCs, SRCCs showed lower level of methylation for GDNF, RORA, MINT25 and KLF7, and higher level for CDH1 compared to PDCs. 24953529

2014

Entrez Id: 999
Gene Symbol: CDH1
CDH1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 PosttranslationalModification BEFREE We consider that the presence of long-DM has a negative impact on the prognosis of PDC patients which may be relevant to a high frequency of promoter methylation of CDH1. 29273724

2017

Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE Promoter methylation of both CDH1 and CDKN2A was encountered more frequently in PDC patients with long-DM than non-DM or short DM. 29273724

2017

Entrez Id: 1087
Gene Symbol: CEACAM7
CEACAM7
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE Analysis of these background-matched samples with DNA microarrays representing 3456 human genes resulted in the identification of candidate genes for PDC-specific markers, including those for AC133 and carcinoembryonic antigen-related cell adhesion molecule 7 (CEACAM7). 12824920

2003

Entrez Id: 1072
Gene Symbol: CFL1
CFL1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE UGP2 and CFL1 expression in PDC were positively correlated. 29347944

2018

Entrez Id: 1180
Gene Symbol: CLCN1
CLCN1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 GeneticVariation BEFREE Clinical features were evaluated, and all subjects were screened for MR-1, SLC2A1, and CLCN1 genes, which are the causative genes of paroxysmal nonkinesigenic dyskinesia (PNKD), paroxysmal exertion-induced dyskinesia, and myotonia congenita (MC), respectively. 27098784

2016

Entrez Id: 1364
Gene Symbol: CLDN4
CLDN4
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE These findings suggest that targeting CLDN4 might increase the effectiveness and safety of anticancer drug therapy in PDC. 31498559

2019

Entrez Id: 2158
Gene Symbol: F9
F9
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE The relatively low prevalence of RET activation in PDCs argues against a major role for RET/PTC in the progression from well to poorly differentiated thyroid tumor phenotypes. 11788678

2002

Entrez Id: 2643
Gene Symbol: GCH1
GCH1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE To date gene loci have been identified in at least six autosomal dominant forms, i.e., in idiopathic torsion dystonia (9q34), focal dystonia (18p), adult-onset idiopathic torsion dystonia of mixed type (8p21-q22), dopa-responsive dystonia (14q22.1-q22.2), and paroxysmal dystonic choreoathetosis (2q25-q33; 1p21-p13.3). 10737119

1998

Entrez Id: 115482713
Gene Symbol: H3P10
H3P10
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 PosttranslationalModification BEFREE Recently promoter methylation of E-cadherin1 (CDH1) and CDKN2A genes, encoding E-cadherin and P16 respectively, are invoked in development of PDC. 29273724

2017

Entrez Id: 3091
Gene Symbol: HIF1A
HIF1A
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE In addition to the characteristic distribution of ARG2-expressing CAFs, such CAFs co-expressed carbonic anhydrase IX, SLC2A1, or HIF-1α, markers of hypoxia, in PDC tissue. 23424623

2013

Entrez Id: 3146
Gene Symbol: HMGB1
HMGB1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 Biomarker BEFREE In contrast, inhibition of HMGB1 restored pDC phenotype. 25492101

2015

Entrez Id: 3342
Gene Symbol: HTC2
HTC2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE genome-wide DNA copy number changes were analyzed by microarray CGH in ACC-HGT, 4 with transformation into moderately differentiated adenocarcinoma (MDA) and two into poorly differentiated carcinoma (PDC), 5 solid ACC. 20978318

2010

Entrez Id: 3342
Gene Symbol: HTC2
HTC2
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE Genome wide DNA copy number changes were analyzed by microarray CGH in ACC-HGT, four with transformation into moderately differentiated adenocarcinoma (MDA) and two into poorly differentiated carcinoma (PDC), and five solid ACC. 21541734

2011

Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE B cell adaptor for PI3K (BCAP) promoted many aspects of TLR7-driven lupus-like disease, including <i>Isg15</i> and <i>Ifit1</i> expression in blood and an immature pDC phenotype associated with higher IFN production. 30936294

2019

Entrez Id: 3439
Gene Symbol: IFNA1
IFNA1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE Overexpression of miR-618 reduced the development of PDCs from CD34+ cells in vitro and enhanced their ability to secrete IFNα, mimicking the PDC phenotype observed in SSc patients. 28556560

2017

Entrez Id: 3447
Gene Symbol: IFNA13
IFNA13
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE Overexpression of miR-618 reduced the development of PDCs from CD34+ cells in vitro and enhanced their ability to secrete IFNα, mimicking the PDC phenotype observed in SSc patients. 28556560

2017

Entrez Id: 3447
Gene Symbol: IFNA13
IFNA13
Paroxysmal Nonkinesigenic Dyskinesia 1
0.020 Biomarker BEFREE B cell adaptor for PI3K (BCAP) promoted many aspects of TLR7-driven lupus-like disease, including <i>Isg15</i> and <i>Ifit1</i> expression in blood and an immature pDC phenotype associated with higher IFN production. 30936294

2019

Entrez Id: 3562
Gene Symbol: IL3
IL3
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE To investigate the PDC phenotype in more detail, a chip-based expression analysis of surface receptors was combined with respective flow cytometry data obtained from fresh PDC, PDC exposed to interleukin-3 (IL-3) and/or herpes simplex virus type 1 (HSV-1). 19824924

2010

Entrez Id: 3778
Gene Symbol: KCNMA1
KCNMA1
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 GeneticVariation BEFREE Emerging evidence suggests the functional BK channel alterations produced by different <i>KCNMA1</i> alleles may associate with semi-distinct patient symptoms, such as paroxysmal nonkinesigenic dyskinesia (PNKD) with GOF and ataxia with LOF. 31427379

2019

Entrez Id: 8609
Gene Symbol: KLF7
KLF7
Paroxysmal Nonkinesigenic Dyskinesia 1
0.010 AlteredExpression BEFREE Among diffuse type GCs, SRCCs showed lower level of methylation for GDNF, RORA, MINT25 and KLF7, and higher level for CDH1 compared to PDCs. 24953529

2014